The FDA has approved dupilumab (Dupixent) for the treatment of allergic fungal rhinosinusitis, a rare form of chronic sinus inflammation driven by hypersensitivity to fungal organisms in the sinuses, in...
New findings from a large, pragmatic trial found that daily full-body emollient application beginning by 9 weeks of age significantly reduced the cumulative incidence of atopic dermatitis by 24 months.
...
In this Roundtable Wrap-Up, we offer an abbreviated version of the roundtable discussion on the evaluation, treatment, and management of patients with moderate-to-severe atopic dermatitis.
The American Academy of Otolaryngology-Head and Neck Surgery Foundation released a set of guidelines that outline evidence-based recommendations on the use of immunotherapy for inhalant allergy for...
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices has released its 2021 adult and pediatric immunization schedules, including interim recommendations on the use...
Peanut allergies may be a widespread, prevalent occurrence but knowledge gaps remain on peanut allergy in the adult population. In a recent study, researchers examined the prevalence and characteristics of...
In a recent study, researchers sought to investigate the sensitivity and specificity of skin tests and specific IgE quantification for the diagnosis of penicillin/β-lactam allergy.
